Association of Statin Use With the Risk of Developing Diabetic Retinopathy
- 1 August 2007
- journal article
- research article
- Published by American Medical Association (AMA) in American Journal of Ophthalmology
- Vol. 125 (8), 1096-9
- https://doi.org/10.1001/archopht.125.8.1096
Abstract
Objective To investigate whether hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) prevent the development of diabetic retinopathy. Methods We conducted a nested case-control study among patients at the Birmingham Veterans Affairs Medical Center, Birmingham, Alabama. Within a study population of male diabetic patients (n = 6441), we identified incident cases of diabetic retinopathy diagnosed between January 1, 1997, and December 31, 2001 (n = 114). Control subjects were selected using incidence density sampling and were matched for diabetes duration. Information regarding filled statin prescriptions was obtained for cases and controls. Results Cases and controls did not differ regarding overall statin use in crude analysis (odds ratio, 1.01; 95% confidence interval, 0.64-1.59) and in multivariate analyses adjusted for age, race, and coexisting medical conditions (odds ratio, 1.00; 95% confidence interval, 0.60-1.67). Conclusion The results of this study do not support an association between statins and diabetic retinopathy.Keywords
This publication has 12 references indexed in Scilit:
- Diabetic Retinopathy in a Multi-ethnic Cohort in the United StatesAmerican Journal of Ophthalmology, 2006
- Ethnicity, Race, and Baseline Retinopathy Correlates in the Veterans Affairs Diabetes TrialDiabetes Care, 2005
- The Prevalence of Diabetic Retinopathy Among Adults in the United StatesAmerican Journal of Ophthalmology, 2004
- Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease?Eye, 2004
- Association of dyslipidemia and effects of statins on nonmacrovascular diseasesClinical Therapeutics, 2004
- Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levelsOphthalmology, 2003
- The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?Eye, 2002
- Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemiaDiabetes Research and Clinical Practice, 2002
- Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factorsBritish Journal of Ophthalmology, 2000
- The Effects of Lipid Lowering on Diabetic RetinopathyAmerican Journal of Ophthalmology, 1991